Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-thrombotic and Glucose loweRing THerapy in diabEtics With CAD Undergoing PCI: a Prospective Multicenter observatIonal Study on Their Use and Implications for Clinical Outcomes - The ARTHEMIS Registry

NCT04481997 is registered in ClinicalTrials.gov with Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA as lead sponsor.

NCT NCT04481997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04481997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-thrombotic and Glucose loweRing THerapy in diabEtics With CAD Undergoing PCI: a Prospective Multicenter observatIonal Study on Their Use and Implications for Clinical Outcomes - The ARTHEMIS Registry
Lead sponsor
Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA
Phase
Observational
Overall status
Completed
Start date
January 11, 2021
Completion date
January 30, 2024
Enrollment
1,000 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease, type2 diabetes mellitus